A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

Christi-Joe’s mother, Josephine Clements, says her daughter, who goes by CJ, has 22q11 Deletion Syndrome. Now considered the ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...

Weight loss jabs, such as Wegovy, have been linked to reduced risk of dementia and seizures – but increased risk of other ...

Idiopathic epilepsy is the most common medical neurologic disorder of dogs and is reported to affect one in every 100 dogs.

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...

Nearly 500 people from the NGO participated in Tata Mumbai Marathon 2025 on January 19. Among them, 287 were individuals with ...

Collaborative research is driving the development of future treatments to ease symptoms of autism and epilepsy. The ...

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and seizures.

Brain tissue samples are essential for scientific research, especially when it comes to brain disorders such as autism ...

Sudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related mortality. Although the underlying ...